EpiCor Immune

Embria News

June 19, 2018

With increasing distribution and sales worldwide, Embria Health Sciences® welcomes Brigitte Welsby as Regional Sales Manager, Eastern USA & Europe. She will be responsible for growing the EpiCor® and eXselen® human nutritional health supplement businesses along the U.S. eastern seaboard, helping to develop...

Read More

April 6, 2018

Embria Health Sciences has adopted EpiCor fermentate as a part of the American Botanical Council’s (ABC) Adopt-an-Herb Program. Through its adoption, Embria Health Sciences helps ABC expand...

Read More

October 26, 2017

Acquisition will accelerate Cargill’s growth and support healthier animals and more wholesome food production

(MINNEAPOLIS) October 24, 2017– Responding to growing consumer preferences for natural and wholesome food production, Cargill today announced it has signed a binding agreement to acquire Diamond V, a leading global provider of innovative natural solutions and technologies that improve animal health, animal performance, and food safety. This acquisition, which follows Cargill’s recent investment in Delacon, the global leader in natural, plant-based phytogenic additives, will give Cargill market-leading participation in the $20 billion global animal feed additives market, as well as world-class technical, regulatory and R&D capabilities and go-to-market strength in approximately 70 countries worldwide.

Read More

September 12, 2017

Consumption of natural immune strength ingredient EpiCor® fermentate results in beneficial modulation of the gut microbiome and improvement of gastrointestinal comfort and constipation, a new study finds. The research was recently published in BMC Complementary and Alternative Medicine.

“The positive results with EpiCor in this study are very encouraging since an ingredient of this kind has never been evaluated for its role in gut microbiota shifts and effects on common constipation-associated symptoms,” says Massimo Marzorati, Ph.D., PostDoc at Ghent University and co-founder of ProDigest, the contract research organization that conducted the trial. “It’s a remarkable finding to see compelling prebiotic effects in a human study at a dose of only 500 mg per day.”

Read More

June 9, 2017

June 9, 2017 – [Ankeny, IA] Embria Health Sciences, LLC, manufacturer of EpiCor® fermentate, has partnered with Nutritional Division of LEHVOSS UK - Gee Lawson to distribute its flagship ingredient to key countries in Western Europe including United Kingdom, Italy, France, Germany...

Read More

May 15, 2017

Fifty-five percent of nutritional supplement users in the U.S. are aware of their gut microbiome, but most are not quite sure what it does.

This data comes from a recent survey of more than 1,000 supplement users conducted by Ankeny, Iowa based Embria Health Sciences using the Qualtrics enterprise research platform. The survey suggests that consumers today know something about key factors affecting gut health. However, their current understanding is far from complete.

Read More

January 31, 2017

Celebrating 10 successful years in business, Embria Health Sciences will be donating 10,000 free bottles of its ingredient EpiCor in a statewide and national Share the Health program. EpiCor fermentate is a safe and natural nutritional supplement with years of human research showing it strengthens the immune and digestive systems to help people live healthier lives.

Read More

June 9, 2016

Read More

June 7, 2016

Read More

May 5, 2016

Ankeny, Iowa - Embria Health Sciences has expanded the market for its groundbreaking fermented immune supplement ingredient EpiCor into Central and Eastern Europe with a new distribution agreement with Hermes Consilium, d.o.o. Through this agreement Hermes Consilium will be the exclusive sales agent for EpiCor within 10 countries – Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Slovenia, Croatia, Serbia and Macedonia...

Read More
Previous
of 3
Showing 1-10 of 25
© 2018 EpiCor Immune. All rights reserved.